Suchergebnisse - "Scigliano, Giulio"

PubPharm (17)

1

Methylene blue in covid-19

enthalten in: Medical hypotheses | 2021

von Scigliano, G. | Scigliano, G.

CommentIn: Med Hypotheses. 2021 May;150:110574. - PMID 33799158

2

Acute respiratory distress syndrome from Covid-19 : A perfect storm from free radicals? Proposal for a new treatment

enthalten in: Medical hypotheses | 2020

von Scigliano, G. | Scigliano, G.

3

Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia : a novel mechanistic hypothesis

enthalten in: CNS drugs | 2013

von Scigliano, G. | Ronchetti, G.

4

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis

enthalten in: CNS drugs | 2013

von Scigliano, G. | Ronchetti, G.

5

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis

enthalten in: CNS drugs | 2013

von Scigliano, G. | Ronchetti, G.

6

Plasma cholesterol and Parkinson's disease : is the puzzle only apparent?

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2010

von Scigliano, G. | Ronchetti, G. | Girotti, F.

7

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease

enthalten in: Parkinsonism & related disorders | 2009

von Scigliano, G. | Ronchetti, G. | Girotti, F. | +1

8

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease

enthalten in: Parkinsonism & related disorders | 2009

von Scigliano, G. | Ronchetti, G. | Girotti, F. | +1

9

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease

enthalten in: Parkinsonism & related disorders | 2009

von Scigliano, G. | Ronchetti, G. | Girotti, F. | +1

10

Levodopa reduces risk factors for vascular disease in parkinsonian patients

enthalten in: Journal of neurology | 2008

von Scigliano, G. | Ronchetti, G. | Girotti, F. | +1